Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Elegen

Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development
From Elegen
Via Business Wire
Elegen Cuts Pricing for ENFINIA™ DNA, Expanding Access to Next-Generation Cell-Free DNA Manufacturing
From Elegen
Via Business Wire
Elegen Now Ships Plasmids Up to 15 kb in Just 10 Business Days, Bringing Unprecedented Speed to Long DNA Synthesis
From Elegen
Via Business Wire
Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing
From Elegen
Via Business Wire
Elegen Launches ENFINIA™ DNA Enhancement for Rapid Synthesis of Highly Complex DNA
From Elegen
Via Business Wire
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology
From Elegen
Via Business Wire
Tickers GSK
Elegen Early Access Partners Receive High-Complexity, Long DNA Sequences in Rapid Time
From Elegen
Via Business Wire
Elegen Launches New Online Ordering Portal for Rapid, High-Accuracy, Long DNA
From Elegen
Via Business Wire
Elegen Launches ENFINIA™ DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
From Elegen
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS